What is InformedDNA?
InformedDNA stands as a leading authority in the appropriate application of genetic testing, leveraging a comprehensive team of board-certified genetics specialists. The company provides essential services including clinical genetic counseling, genetic testing utilization management, and payment integrity solutions. Its expertise is crucial for health plans, health systems, employers, and pharmaceutical companies, ensuring that patients and clinicians benefit from high-quality genetic services. InformedDNA's offerings are designed to optimize the integration of genetic insights into healthcare.
How much funding has InformedDNA raised?
InformedDNA has raised a total of $22.2M across 4 funding rounds:
Private Equity
$7.7M
Unspecified
$3M
Private Equity
$5M
Private Equity
$6.5M
Private Equity (2013): $7.7M, investors not publicly disclosed
Unspecified (2013): $3M led by MPM Capital
Private Equity (2014): $5M supported by Zaffre Investments, LLC.
Private Equity (2016): $6.5M, investors not publicly disclosed
Key Investors in InformedDNA
Zaffre Investments, LLC.
Zaffre Investments, LLC, a subsidiary of Blue Cross Blue Shield of Massachusetts, focuses on healthcare investments aimed at improving healthcare delivery. They are stage-agnostic and partner with companies in areas like health IT and consumer solutions.
MPM Capital
MPM Capital is a venture capital firm specializing in early-stage investments in the biotechnology and life sciences sectors, aiming to translate scientific discoveries into therapeutic solutions.
What's next for InformedDNA?
With substantial enterprise-level backing, InformedDNA is poised to further solidify its market leadership. Future strategies will likely focus on expanding its service portfolio, enhancing its technology infrastructure for genetic data management, and forging deeper partnerships within the healthcare ecosystem. The company's ongoing commitment to genetic expertise suggests a trajectory aimed at influencing broader healthcare policy and clinical practice, driving the adoption of precision medicine through informed genetic testing.
See full InformedDNA company page
